Related Experiment Video
Updated: May 20, 2025

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Au6Cu2 Clusters with High Electron Affinity and Oxygen-Mimetic Properties for Hypoxic Tumor Radiosensitization
Xueli Zhao1, Jingpeng Han1, Junqi Liu2
1Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Henan International Joint Laboratory of Tumor Theranostic Cluster Materials, College of Chemistry, Zhengzhou University, Zhengzhou, China.
None:
Hypoxia-induced radioresistance primarily contributes to the failure of radiotherapy because it hinders the effective fixation of DNA damage. Despite the considerable antitumor activity of chemical molecules such as electron-affinic nitroimidazoles affirmed by clinical studies, their dose-dependent side effects and low radiotherapy efficacy have become major drawbacks. In this study, we synthesized nitrobenzene-functionalized Au6Cu2 (NO2-Au6Cu2) clusters, integrating metal clusters with chemical radiosensitizers. The ligand 4-nitrophenylacetylene's hypoxia-selective toxicity arises from reductase-mediated radical generation under hypoxia, depleting GSH and compromising radiotherapy ROS clearance. Our findings indicate that the electron affinity of interfacial ligands has a significant effect on the electron affinity and hypoxic cytotoxicity of metal clusters. Experimental results demonstrated that NO2-Au6Cu2 clusters exhibit a high sensitization enhancement ratio by leveraging the properties of gold clusters to augment radiotherapy and the oxygen-mimetic property of chemical molecules to impair DNA repair pathways. This research introduces a novel strategy for developing highly efficient metal cluster-based hypoxic radiosensitizers.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

